Specific Panels

Individualized therapeutic strategies

ATHERO-PANEL –Cardiovascular Risk Profile

“Most risk factors for vascular disease are modifiable”

Cardiovascular diseases represent one of the main cases of morbidity-mortality in developed countries, and the heavy involvement of vascular risk in cerebrovascular pathologies, dementias, Alzheimer’s disease, etc. has been proven. These factors promote the current interest in the development of predictive risk markers for the early preventive treatment of these disorders.

Objective: Prevention
Most risk factors for vascular disease are modifiable. That is to say, they can be corrected, causing a reduction in the risk of infarction and death by vascular disease.

Currently, based on these biomarkers, it is possible to carry out a highly accurate risk stratification, helping to identify persons at high risk, in whom we must maximize the educational aspects and the treatment and monitoring measures.

OXIDATIVE STRESS –Total Antioxidant Capacity

“Regulates the battle against the free radicals involved in aging and in numerous pathologies”

Determining the Total Antioxidant Status enables the assessment of the integrated antioxidant system, which implicates all the biological components with antioxidant activity. Oxidative stress has been associated with the pathogenesis of many human diseases, and this is why the use of antioxidants in pharmacology is under intensive study, particularly as a treatment for cerebrovascular accidents and neurodegenerative diseases. Antioxidants are used widely in dietary supplements to preserve health and to help prevent diseases such as cancer and ischemic cardiopathy. The monitoring of oxidant status by a specialist with balanced diets and supplements can be a benefit to the health and can forestall certain diseases.

Who is it targeted at?

  • The identification of patients at risk of diseases such as cancer, coronary diseases, rheumatoid arthritis, diabetes, retinopathy and age-related conditions.
  • The identification of patients with poor nutritional status.
  • Determination of the antioxidant potential of foodstuffs.
  • Determination of the therapeutic efficacy and antioxidant potential of drugs.

OSTEOPANEL – Bone Metabolism Panel

“Of help in the early diagnosis, prevention and efficacy of the treatment of OSTEOPOROSIS”

Osteoporosis is the most common bone metabolism disease, and is responsible for most fractures occurring in persons over 50 years of age.

Factors predisposing an individual to developing osteoporosis
An inadequate intake of calcium and Vitamin D in infancy, the use of steroid-containing drugs, anorexia, sedentarism, tobacco use and the excessive intake of alcohol are factors which increase the risk of osteoporosis during the lifespan, as do some diseases. Those persons with a family history of osteoporosis may also be at greater risk.
Recommendations for osteoporosis screening
Although it may affect anybody, the risk of developing osteoporosis increases with age and affects more women than men; it is also more common in Caucasians and Asians.
Why is the Osteopanel useful?
The purpose of the tests is to discover if the person suffers osteoporosis, has an imbalance in bone remodeling and is therefore at greater risk of developing the disease, is menopausal and/or presents hormone deficiency, or is suffering from a disease that might cause or aggravate the loss of bone mass.

GRASOPANEL –Metabolic Syndrome Panel

“Accurate, reliable diagnosis of the METABOLIC SYNDROME”

“Metabolic Syndrome” (MS) is the name given to the ensemble of metabolic disruptions comprising centrally-distributed obesity, decreased concentrations of high-density lipoprotein cholesterol (HDL-C), elevated triglyceride concentrations, an increase in blood pressure (BP), and hyperglycemia.

Why is the “Grasopanel” useful?

The “GRASOPANEL” deals with each of the diagnostic bases of MS (Insulin resistance, Obesity and increased abdominal girth, Dyslipidemia, Hypertension and Oxidative stress), thus to provide a safe, rigorous diagnosis of MS in a single test.
In addition, other biochemical parameters not included in diagnostic criteria but involved in the development of MS are studied; these, being modifiable, may aid us in its prevention.
Implications of MS
The presence of the metabolic syndrome increases cardiovascular risk and the risk of developing type II diabetes. A 10-year vascular risk report according to an algorithm such as the Score® tables and a screen of your genetic predisposition to developing MS would help in its prevention and in the design of a more suitable personalized therapy, either by simply modifying the lifestyle or establishing a pharmacological treatment, according to the degree of risk.